Article
Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol.
European journal of nutrition - 1 Jun 2002
Corbalán M S, Marti A, Forga L, Martínez-González M A, Martínez J A
Abstract excerpt
OBJECTIVE AND DESIGN: A case-control study was conducted to examine the association between the 27Glu polymorphism of the beta(2)-adrenergic receptor gene (ADRB2) and the risk of abdominal obesity (defined by a waist/hip ratio: WHR higher than 0.85). METHODS: The case series encompassed 112 obese subjects with body mass index (BMI) > 30 kg/m(2) and WHR > 0.85 and no other major disease except for type 2 diabetes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
